Quick answers
- What is Questran?
- Questran is a brand name of Cholestyramine, a prescription medicine. The FDA NDC Directory lists 2 Questran products in 2 strengths and forms.
- Who makes Questran?
- PH Health holds the FDA application for Questran (ANDA077203, approved August 26, 2005).
- Is there a generic or store brand of Questran?
- Yes. The FDA NDC Directory lists 17 other products with the same active ingredients, strength and form as a Questran product, 17 of them generic. Ask your pharmacist whether one is right for you.
- Has Questran been recalled?
- No recall linked to Questran products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Questran is
Each Questran product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Cholestyramine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| cholestyramine 4 g/5 g powder, for suspension (oral) | Questran | 3 products, 2 companies | DailyMed |
| cholestyramine 4 g/9 g powder, for suspension (oral) | Questran | 14 products, 11 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cholestyramine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA077203 | PH Health | August 26, 2005 | 1 |
| ANDA077204 | PH Health | August 26, 2005 | 1 |
Companies that list Questran
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Questran products.
- Par Health USA, LLC2 products
Recalls
No recall linked to Questran products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.